Testosterone Base

Striant and Testoderm, have patent expirations of August 23, 2019 and November 10, 2019, respectively. The National Institutes of Health states that approximately 5 million American men do not produce enough of the hormone testosterone. Axiron is a highly profitable testosterone replacement therapy, with a patent expiration of February 19, 2017. The testosterone replacement Axiron generated over $48 million dollars in profit in 2011. Coined “The Wittert Study”, after Gary Wittert who is the leader of this study, this novel study is banking on being the first of many to address the worldwide epidemic of type 2 diabetes using testosterone treatment as a preventative. The International Diabetes Federation has stated that the cost to treat type 2 diabetes worldwide now hovers at 471 billion dollars.

Please Note that this information was issued on BestB2B.com!

Insulation Panel,roof panels2024-01-29

EPS sandwich panel2024-01-29

Insulated Metal Panels Increas2024-01-29

Insulated Metal Roof Panel2024-01-29

Light Insulated Metal Wall Pa2024-01-29

Insulated Metal Wall Panels2024-01-29

Insulated sandwich panels / In2024-01-29

Trapezoidal Roof Panel / Wall2024-01-29

100G QSFP28 SWDM4 100m LC Opti2024-02-01

100G QSFP28 SR4 100M MPO Optic2024-02-01

200G QSFP56 SR4 100m MPO Optic2024-02-01

400G OSFP SR8 100m MPO Optical2024-02-01

400G QSFP-DD LR8 10KM LC Optic2024-02-01

400G QSFP-DD LR4 10KM LC Media2024-02-01

400G QSFP-DD 4x100G LR 10KM 2024-01-29